Literature DB >> 25818952

Accuracy of HLA-DQ genotyping in combination with IgA anti-tissue transglutaminase serology and a "scoring system" for the diagnosis of celiac disease in Turkish children.

Murat Çakır1, Maşallah Baran, Fahri Uçar, Ulaş Emre Akbulut, Neşe Kaklıkkaya, Şafak Ersöz.   

Abstract

The aim of the study was to analyze the accuracy of (i) HLA-DQ typing and anti-tissue transglutaminase antibodies immunoglobulin A (tTG-IgA) serology and (ii) a "simple scoring system" (SSS) for the diagnosis of celiac disease (CD). The study included 91 patients with positive tTG-IgA, who had been tested for HLA-DQ. Patients were divided into 3 groups: typical CD, atypical CD, and non-CD. The sensitivity, specificity, positive (PPV) and negative predictive value (NPV), positive (PLR) and negative likelihood ratio (NLR) and accuracy of the test combining genotyping and tTG-IgA positivity and the simple scoring system for the diagnosis of CD were evaluated. The combination of genotyping and strong tTG-IgA positivity had a sensitivity of 93.5%, specificity of 61.5%, PPV of 93.5%, NPV of 61.5%, PLR of 2.4, NLR of 0.1 and accuracy of 89% for "CD." SSS had a higher specificity (84.6%), higher PPV (97.3%), higher NPV (68.7%), higher PLR and higher accuracy (92.3%). The combination of genotyping and strong tTG-IgA positivity missed two patients with typical CD (4%) and three patients with atypical CD (10.7%). Two cases with malabsorptive symptoms (33.3%) and three patients without malabsorptive symptoms (42.8%) would have been misdiagnosed as CD if these tests were used. Intestinal biopsy is still mandatory for diagnosis of CD in Turkish children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25818952

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  5 in total

1.  HLA-DQ genetics in children with celiac disease: a meta-analysis suggesting a two-step genetic screening procedure starting with HLA-DQ β chains.

Authors:  Annalisa De Silvestri; Cristina Capittini; Dimitri Poddighe; Chiara Valsecchi; Gianluigi Marseglia; Sara Carlotta Tagliacarne; Valeria Scotti; Chiara Rebuffi; Annamaria Pasi; Miryam Martinetti; Carmine Tinelli
Journal:  Pediatr Res       Date:  2018-01-17       Impact factor: 3.756

2.  Classical celiac disease is more frequent with a double dose of HLA-DQB1*02: A systematic review with meta-analysis.

Authors:  Judit Bajor; Zsolt Szakács; Nelli Farkas; Péter Hegyi; Anita Illés; Margit Solymár; Erika Pétervári; Márta Balaskó; Gabriella Pár; Patrícia Sarlós; Ákos Szűcs; József Czimmer; Kata Szemes; Orsolya Huszár; Péter Varjú; Áron Vincze
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

3.  IL-15 Gene Polymorphism in Celiac Disease Patients and Their Siblings.

Authors:  Yalçın Kara; Makbule Eren; Serap Arslan; Oğuz Çilingir
Journal:  Turk J Gastroenterol       Date:  2021-04       Impact factor: 1.852

4.  Celiac disease in children: Increasing prevalence and changing clinical presentations.

Authors:  Hasan M Isa; Eman Farid; Jaafar J Makhlooq; Afaf M Mohamed; Jumana G Al-Arayedh; Fawzeya A Alahmed; Shima Medani
Journal:  Clin Exp Pediatr       Date:  2020-10-17

5.  TagSNP approach for HLA risk allele genotyping of Saudi celiac disease patients: effectiveness and pitfalls.

Authors:  Reham H Baaqeel; Babajan Banaganapalli; Hadiah Bassam Al Mahdi; Mohammed A Salama; Bakr H Alhussaini; Meshari A Alaifan; Yagoub Bin-Taleb; Noor Ahmad Shaik; Jumana Yousuf Al-Aama; Ramu Elango; Omar I Saadah
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.